Clinical Trial Update: Safety and Tolerability Study of Levalbuterol HFA and Racemic Albuterol HFA in Pediatrics Subjects With Asthma [Phase 2]

View source ↗

Summary

Phase 2 pediatric safety and tolerability trial comparing levalbuterol HFA with racemic albuterol HFA in children with asthma; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Levalbuterol HFA (levalbuterol)
• Racemic Albuterol HFA (albuterol)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Asthma | Phase 2 | Status: COMPLETED